/ Print /

Politics and Policy

Opinion: Medicare for all: Imminent or pipe dream?As the nation debates the future of our healthcare system, one idea gaining attention is a “Medicare-for-all” single-payer national health insurance plan.
4 things to know about second failed GOP healthcare billHere’s a look at four changes in the second round of healthcare bill revisions that just weren’t enough to muster up enough votes.
Four things to watch in Senate Obamacare replacementHealthcare analysts offer four things MCOs should know about the Better Care Reconciliation Act or BCRA.
AHCA next steps: 4 things MCOs should knowWhat are the next steps for the bill, and how likely is it that it will become law? Here’s are four things MCOs should know.
Opinion: Biggest problems with single-payer ‘Medicare-for-all’Our policy analyst explains why he believes single payer Medicare-for-all is a pipe dream.
Congress considering ‘invisible’ high-risk poolsOur policy analyst explains the concept of invisible high-risk pools, and explains how they might affect health reform.
Four reasons GOP ACA replacement failed without a voteWhat exactly did House representatives on both sides of the aisle dislike about the AHCA? Here’s a look at what MCOs should know.
State medical marijuana laws continue to expandMedical marijuana’s therapeutic evidence base remains nascent and controversial but the regulatory landscape is evolving rapidly.
Five things to know about Trump’s FDA lead pick GottliebOn March 10, the White House announced that President Donald Trump selected Scott Gottlieb, MD, who has worked for FDA in the past, as his choice to head the FDA. Here are five things managed healthcare executives should know about the pick.
Opinion: More industry-stakeholders play blame game for high drug costsOur policy analyst weighs in on a new drug industry PR campaign that attempts to shift the blame for high drug costs.